The ISTH-BAT (Bleeding Assessment Tool)

Introduction

The ISTH-BAT (International Society on Thrombosis and Haemostasis Bleeding Assessment Tool) is a standardized questionnaire used to quantify a person's lifetime bleeding history. Rather than relying on a clinician's subjective impression of "easy bruising" or "heavy periods," the ISTH-BAT assigns a structured score across 14 bleeding symptom categories, from epistaxis and gum bleeding to menorrhagia, postpartum hemorrhage, and bleeding after surgery or tooth extraction.

Each symptom is graded by severity, and the scores are summed into a single bleeding score (BS). The tool was developed to replace the older Vicenza and MCMDM-1 VWD questionnaires with a shorter, harmonized instrument suitable for both research and everyday clinical use [1]. It is used primarily by hematologists, but also by general practitioners, gynecologists, and specialist nurses, to decide who genuinely needs laboratory testing for a bleeding disorder such as von Willebrand disease (VWD), a platelet function disorder, or a mild factor deficiency. Because the general population also reports occasional minor bleeding symptoms, the ISTH-BAT's real value lies in distinguishing a mild, self-limited bleeding history from one that reflects an underlying hemostatic disorder.

How the ISTH-BAT Is Scored

The tool covers 14 symptom domains:

Each domain is graded on a standardized 0 to 4 severity scale based heavily on the level of medical intervention required:

0: Symptom absent, or the domain has never been challenged (e.g., never had surgery).

1: Symptom present but self-managed; no medical attention sought.

2: Medical consultation sought, but no targeted intervention required. (For example, noticing occasional bruises from minor bumps scores a 1, but simply bringing that bruising to the attention of a medical professional automatically elevates the score to a 2).

3: Active medical intervention required (e.g., iron therapy, prescription medication, nasal cautery).

4: Critical intervention required (e.g., blood transfusion, factor replacement, or surgery to stop bleeding).

The scores across all domains are added together to give the total bleeding score. A domain that has never been challenged (for example, a patient who has never had surgery or given birth) is scored 0 by convention rather than left blank, since an "untested" hemostatic system cannot be assumed to be abnormal.

ISTH-BAT Score Tool

Interpreting the ISTH-BAT Score

Normal bleeding scores differ by age and sex, because healthy people naturally report more minor bleeding symptoms as they accumulate more hemostatic "challenges" like childbirth, surgery, or menstruation over a lifetime.

Established normal reference ranges have been recently updated to reflect that healthy individuals (particularly women) accumulate more hemostatic challenges over their lifetime [4]. The updated reference ranges are:

• Adult men: 0–3 (Abnormal is ≥ 4)
• Adult women (18–30 years): 0–4 (Abnormal is ≥ 5) [4]
• Adult women (31–51 years): 0–5 (Abnormal is ≥ 6) [4]
• Adult women (≥ 52 years): 0–6 (Abnormal is ≥ 7) [4]
• Children (< 18 years): 0–2 (Abnormal is ≥ 3). However, for adolescent females presenting specifically with heavy menstrual bleeding, an ISTH-BAT score >4 is now proposed as the threshold for abnormality to prevent over-investigation [4].

A score above these thresholds is considered abnormal and warrants further hematologic evaluation, most commonly a von Willebrand factor panel and platelet function testing. However, a normal ISTH-BAT does not completely exclude a bleeding disorder, and a raised score does not confirm one; the tool is a screening aid, not a diagnostic test. It works best as the first step that determines who should proceed to laboratory investigation, similar to how the Wells' score determines who should proceed to D-dimer or ultrasound in suspected DVT.

Higher scores also correlate with disease severity once a diagnosis is made. Studies in confirmed VWD and platelet function disorders show that higher median ISTH-BAT scores track with more severe or more numerous bleeding symptoms, and in prospective follow-up, higher scores have been associated with a greater likelihood of needing intensive hemostatic treatment [2,3].

Case Scenarios

Scenario 1: Normal score, no further testing needed

A 24-year-old woman is referred after mentioning easy bruising to her GP. Because she sought medical evaluation for occasional bruises from minor bumps. She has normal periods and no history of surgery or dental extractions requiring intervention. 

Calculator Exercise: What is her total score?

Clinical Interpretation: Her total ISTH-BAT score is 2. Since this falls within the normal female reference range (0–5), no further hematologic workup is triggered based on the bleeding history alone.

---

Scenario 2: Abnormal score, prompts VWD workup

A 19-year-old man reports frequent nosebleeds requiring cautery in childhood, prolonged bleeding after a tooth extraction that needed a return visit to the dentist, and a bruising tendency.

Calculator Exercise: What is his total score?

Clinical Interpretation: His total ISTH-BAT score is 6 - cauterization scored 3 for active intervention, a return visit to the dentist scored 2 for consultation and bruising tendency scored 1. This exceeds the normal male reference range (0–3). He is referred for von Willebrand factor antigen, von Willebrand factor activity, and Factor VIII testing, which return low von Willebrand factor levels consistent with type 1 VWD.

---

Scenario 3: Elevated score in a woman with heavy periods

A 29-year-old woman presents with lifelong heavy menstrual bleeding requiring iron supplementation, one episode of significant bleeding after a Cesarean section requiring transfusion, and occasional gum bleeding while brushing.

Calculator Exercise: What is her total score?

Clinical Interpretation: Her total ISTH-BAT score is 8 - iron supplementation scored 3, blood transfusion scored 4 and gum bleeding scored 1. This is well above the normal female range (0–5). Menorrhagia is one of the most common presenting symptoms of VWD in women, and this history appropriately prompts referral to a hematologist for further testing, alongside gynecologic evaluation to exclude structural causes of heavy bleeding.

Limitations of the ISTH-BAT

The tool depends on accurate recall of bleeding events, which can be affected by memory, age, and how thoroughly a clinician takes the history. It also performs less well in children, in whom exposure to hemostatic "challenges" like surgery or childbirth is limited, and in distinguishing platelet function disorders from healthy variation, where sensitivity and specificity are more modest than in VWD [3]. As with the Wells' score in DVT, the ISTH-BAT is meant to guide the decision to test, not to replace laboratory diagnosis.

Furthermore, because "untested" domains automatically score 0, the tool inherently suppresses total scores in children and young men who have not yet faced significant hemostatic challenges (like surgery or childbirth) [4]. Because of this masking effect, the 2021 joint guidelines by the American Society of Hematology (ASH), ISTH, National Hemophilia Foundation (NHF), and World Federation of Hemophilia (WFH) emphasize a crucial caveat: while the ISTH-BAT is strongly recommended as an initial screening tool in primary care settings, a normal score should not preclude specific laboratory testing if a clinician has a high index of suspicion (e.g., a strong family history of bleeding) [5].

Disclaimer: This article is intended for educational and informational purposes only. It is not intended to be a substitute for informed professional medical advice, diagnosis, or treatment. While the information presented here is derived from credible medical sources and is believed to be accurate and up-to-date, it is not guaranteed to be complete or error-free. See additional information.

References

1. Rodeghiero, F., Tosetto, A., Abshire, T., Arnold, D. M., Coller, B., James, P., Neunert, C., Lillicrap, D., & ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group (2010). ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. Journal of thrombosis and haemostasis : JTH, 8(9), 2063–2065. https://doi.org/10.1111/j.1538-7836.2010.03975.x
2. Adler, M., Kaufmann, J., Alberio, L., & Nagler, M. (2019). Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders. Journal of thrombosis and haemostasis : JTH, 17(7), 1104–1112. https://doi.org/10.1111/jth.14454
3. Deforest, M., Grabell, J., Albert, S., Young, J., Tuttle, A., Hopman, W. M., & James, P. D. (2015). Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia, 21(5), e384–e388. https://doi.org/10.1111/hae.12747
4. Atiq, F., Christopherson, P. A., Doherty, D., Hulshof, A. M., Haberichter, S. L., Flood, V. H., Lavin, M., O'Connell, N. M., Ryan, K., Byrne, M., Grabell, J., James, P. D., Lillicrap, D., Montgomery, R. R., Di Paola, J., & O'Donnell, J. S. (2025). Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program. Blood advances, 9(19), 4780–4789. https://doi.org/10.1182/bloodadvances.2025016725
5. James, P. D., Connell, N. T., Ameer, B., Di Paola, J., Eikenboom, J., Giraud, N., Haberichter, S., Jacobs-Pratt, V., Konkle, B., McLintock, C., McRae, S., R Montgomery, R., O'Donnell, J. S., Scappe, N., Sidonio, R., Flood, V. H., Husainat, N., Kalot, M. A., & Mustafa, R. A. (2021). ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood advances, 5(1), 280–300. https://doi.org/10.1182/bloodadvances.2020003265